[ET Net News Agency, 2 September 2026] HENGRUI PHARMA (01276) fell 1.6% to HK$45.56.
It hits an intra-day low of HK$45.52, hitting a historical low, and an intra-day high of HK$46.34. The total shares traded was 286,700, with a value of HK$13.12m. The active buy/sell ratio is 17:83, with net selling turnover of HK$8.17m. CHINA INV INFO accounts for greatest net responsive buying turnover of HK$1.26m, with volume weighted average price of HK$45.935. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive selling turnover of HK$355,773, with volume weighted average price of HK$46.005.
Basic Information| Nominal | 45.560 | % Chg | -1.64% |
| High | 46.340 | Low | 45.520 |
| Shares Tr | 286,700 | Turnover | 13.12m |
| 10-D SMA | 47.224 | %H.V | 51.016 |
| 20-D SMA | 51.464 | VWAP | 45.776 |
| 50-D SMA | 55.260 | RSI14 | 30.417 |
Status: Hitting a historical low, active buy/sell ratio is 17:83, with net selling turnover of HK$8.17m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HENGRUI PHARMA (01276) | 45.560 | -1.64 |
| SIHUAN PHARM (00460) | 0.750 | +1.35 |
| GRAND PHARMA (00512) | 4.990 | -0.70 |
| SBP GROUP (01177) | 5.240 | -0.38 |
| LIVZON PHARMA (01513) | 20.060 | -0.59 |
| LUYE PHARMA (02186) | 1.885 | -0.79 |
| FOSUN PHARMA (02196) | 16.050 | -0.37 |
| SH PHARMA (02607) | 11.500 | -0.52 |
| CHINARES PHARMA (03320) | 4.440 | -0.11 |
| HANSOH PHARMA (03692) | 34.640 | +0.81 |
(ed)
